937738-85-7Relevant articles and documents
Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at μ and δ opioid receptors
Lee, Yeon Sun,Nyberg, Joel,Moye, Sharif,Agnes, Richard S.,Davis, Peg,Ma, Shou-wu,Lai, Josephine,Porreca, Frank,Vardanyan, Ruben,Hruby, Victor J.
, p. 2161 - 2165 (2007)
New 4-anilidopiperidine analogues in which the phenethyl group of fentanyl was replaced by several aromatic ring-contained amino acids (or acids) were synthesized to study the biological effect of the substituents on μ and δ opioid receptor interactions. These analogues showed broad (47 nM-76 μM) but selective (up to 17-fold) binding affinities at the μ opioid receptor over the δ opioid receptor, as predicted from the message-address concept.
Development of potent μ and δ opioid agonists with high lipophilicity
Lee, Yeon Sun,Kulkarani, Vinod,Cowell, Scott M.,Ma, Shou-Wu,Davis, Peg,Hanlon, Katherine E.,Vanderah, Todd W.,Lai, Josephine,Porreca, Frank,Vardanyan, Ruben,Hruby, Victor J.
, p. 382 - 386 (2011/03/18)
An SAR study on the Dmt-substituted enkephalin-like tetrapeptide with a N-phenyl-N-piperidin-4-ylpropionamide moiety at the C-terminal was performed and has resulted in highly potent ligands at μ and δ opioid receptors. In general, ligands with the substi